Value in Health · 2020 · 24 citations · 22 references
PharmacyClinical PharmacyPharmacotherapyDecision TheoryDiabetologyConsumer ChoiceDiabetes ManagementDiabetes MellitusDiscrete Choice ModelsGlycemic ControlPatient PreferencesAdherence To Diabetes MedicationsDiabetes Medication UseDiscrete Choice Experiment DesignDiscrete Choice ModellingElicited Treatment PreferencesEliciting Patient PreferencesMedication Preference AssessmentType 2 Diabetes Treatment
22
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey et al. · New England Journal of Medicine · 2017 · 7.8K citations · Full text
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse et al. · Diabetes Care · 2014 · 3.1K citations · Full text
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong et al. · New England Journal of Medicine · 2015 · 2.6K citations · Full text